Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025

This study predicts the burden of incident osteoporosis‐related fractures and costs in the United States, by sex, age group, race/ethnicity, and fracture type, from 2005 to 2025. Total fractures were >2 million, costing nearly $17 billion in 2005. Men account for >25% of the burden. Rapid growth in the disease burden is projected among nonwhite populations.

[1]  S Phillips,et al.  The direct medical costs of osteoporosis for American women aged 45 and older, 1986. , 1988, Bone.

[2]  S. Furner,et al.  Musculoskeletal Conditions in the United States , 1992 .

[3]  R. Wallace,et al.  Costs and health effects of osteoporotic fractures. , 1994, Bone.

[4]  E. Barrett-Connor.  The economic and human costs of osteoporotic fracture. , 1995, The American journal of medicine.

[5]  L. Melton,et al.  Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  L. Plouffe,et al.  Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risks. , 1999, Journal of women's health & gender-based medicine.

[7]  E. Seeman,et al.  Osteoporosis in Men , 1999, Osteoporosis International.

[8]  W. O'Fallon,et al.  Fracture Incidence in Olmsted County, Minnesota: Comparison of Urban with Rural Rates and Changes in Urban Rates Over time , 1999, Osteoporosis International.

[9]  H K Genant,et al.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. , 1999, JAMA.

[10]  T. Abbott,et al.  Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  S. Cummings,et al.  Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. , 2000, The Journal of clinical endocrinology and metabolism.

[12]  M. Hooper,et al.  Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis , 2000, Osteoporosis International.

[13]  B. O'brien,et al.  Challenges for Model-Based Economic Evaluations of Postmenopausal Osteoporosis Interventions , 2001, Osteoporosis International.

[14]  Michael C. Nevitt,et al.  Fracture Risk Reduction With Alendronate in Women With Osteoporosis: The Fracture Intervention Trial , 2001 .

[15]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[16]  D. Felsenberg,et al.  Pharmacoeconomic analysis of osteoporosis treatment with risedronate. , 2003, International journal of clinical pharmacology research.

[17]  A. Tosteson,et al.  Short-Term Cost-Effectiveness of Bisphosphonate Therapies for Postmenopausal Osteoporotic Women at High Risk of Fracture , 2003 .

[18]  N. Col,et al.  Estimating Hip Fracture Morbidity, Mortality and Costs , 2003, Journal of the American Geriatrics Society.

[19]  R. Burge,et al.  Methodology for estimating current and future burden of osteoporosis in state populations: application to Florida in 2000 through 2025. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[20]  Jacques P. Brown,et al.  Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. , 2004, Clinical therapeutics.

[21]  E. Arias.  United States Life Tables, 2001. , 2004, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[22]  V. Mor,et al.  Recent trends in state nursing home payment policies. , 2004, Health affairs.

[23]  S. Oparil,et al.  Ethnicity and Blood Pressure , 2005, Journal of clinical hypertension.

[24]  D. Bates,et al.  Determinants of racial/ethnic differences in blood pressure management among hypertensive patients , 2005, BMC Cardiovascular Disorders.

[25]  C. Saha,et al.  Individual and neighborhood-level factors in predicting asthma. , 2005, Archives of pediatrics & adolescent medicine.

[26]  R. Burge,et al.  Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment , 2005, Osteoporosis International.

[27]  Bernard Friedman,et al.  Racial/ethnic disparities in potentially preventable readmissions: the case of diabetes. , 2005, American journal of public health.

[28]  J. Reginster,et al.  Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. , 2005, The Journal of clinical endocrinology and metabolism.